Plants synthesize a variety of phenolic compounds via the phenylpropanoid pathway, which is a pathway unique to plants [1] . These phenolic compounds found in nature can be classified based on the backbone of their carbon skeleton (Table 1) . Phenolic acid, whose carbon skeleton is benzoic acid derivatives (C6-C1), phenylethanoid (C6-C2), phenylpropanoid (C6-C3), stilbene (C6-C2-C6), and flavonoid (C6-C3-C6) are major groups [2] .
Diverse phenolic compounds are being widely used in our current life. Some of them are building blocks for polymer synthesis [3] , some are used as ingredients in food [4] , and some of them are considered bioactive compounds that have potential for the development of new medicines [5] . The antioxidant activity of phenolic compounds is conspicuous, but additional biological activities have been revealed using extracts from diverse plants. These include anticancer, anti-inflammatory, antibacterial, antiviral, antifungal, anticoagulant, and antihypertensive activities [6] [7] [8] [9] .
The phenylpropanoid pathway, which uses amino acids phenylalanine or tyrosine, leads to the synthesis of diverse phenolic compounds. Genes involved in phenolic compounds biosynthesis have been cloned and characterized from model plants such as Arabidopsis thaliana and Oryza sativa to medicinal plants [1] . These genes have been expressed in microorganisms to produce value-added phenolic compounds.
Among the phenolic compounds, phenylethanoids, which have a C6-C2 carbon skeleton, and the biological pathway for phenylethanoid synthesis is beginning to be elucidated. In this review, we focus on the recent developments in phenylethanoid biosynthesis using engineered microorganisms.
Classification and Biological Activities of Phenylethanoids
Phenylethanoids have a phenethyl alcohol structure and 2-phenylethanol (2-PE), tyrosol, and hydroxytyrosol are typical examples of phenylethanoids. Phenylethanoids may be conjugated with glycosides and hydroxycinnamoic acids (HCs) in limited plant families [9, 10] . Phenylethanoid glycosides are found in various medicinal plants and more than 300 new phenylethanoid glycosides have been identified in the last twenty years [9, 10] . Synthesis of phenylethanoid glycosides is not well investigated. Salidroside (2-(4-hydroxyphenyl) ethyl β−D-glucopyranoside), one of the phenylethanoid glycosides found in the medicinal plant Rhodiolarosea is a tyrosol glucoside and is thought display antidepressant and anxiolytic activities [11] . 2-PE forms an ester conjugate with caffeic acid called CAPE (caffeic acid phenethyl ester), which is one of constituents of propolis [12] .
2-PE is a flavor compound that is widely used in the cosmetic and food industries. Plants are the major source of 2-PE and there are some limitations to supply the demands from market. Tyrosol and hydroxytyrosol are major ingredients of olive oil and are known antioxidants [13] . Both compounds show neuroprotective activity against amyloid β formation and therefore help prevent Alzheimer's disease [14] and release neuropathy [15] . These two compounds were known to prevent atherosclerosis and cancer, and display anti-inflammatory activities [16] . Therefore, they have potential uses in cardiovascular diseases, cancer, and AIDS [17] . Salidroside confers protection from brain cell damage [18] and bone loss [19] and reduces the side effects of chemotherapy [20] .
CAPE is known to possess various biological activities including anticancer, antimicrobial, antioxidant, and antiinflammatory activities [21, 22] . CAPE also shows antiasthmatic activity and inhibits 5-lipoxygenase and leukotriene biosynthesis more effectively than the clinically-approved Zileuton [23] . CAPE or its derivatives have been synthesized chemically [24] [25] [26] . The caffeic acid moiety and/or phenylethanol moiety of CAPE were changed and 19 derivatives were synthesized [25] . Some of these derivatives showed better cytoprotective or neuritogenic activities than CAPE. These CAPE derivatives showed diverse activities including anti-cancer, anti-inflammatory, and immunomodulatory activities [25] .
Phenylethanoid Synthesis in Microorganisms
Biological synthesis of phenylethanoids has been studied and 2-PE and tyrosol are known to be synthesized from phenylalanine and tyrosine, respectively (Fig. 1) . In Saccharomyces cerevisiae, three genes (Aro9, Aro10, and Adh2), all of which are part of the Ehrlich pathway [27] , are involved in the synthesis of 2-PE from phenylalanine. Phenylalanine deaminase (Aro9) modifies phenylalanine to form phenylpyruvate, and phenylpyruvate decarboxylase (Aro10) catalyzes conversion of phenylpyruvate to phenylacetaldehyde, which is reversibly converted into 2-phenylethanol by alcohol dehydrogenase (Adh2) (Fig. 1A ) [28] . In plants, there are two putative pathways for tyrosol synthesis (Fig. 1B) . The first pathway is mediated by two enzymes, an aromatic amino acid decarboxylase such as phenylalanine decarboxylase (PDC) and tyrosine decarboxylase (TDC), and a monoamine oxidase such as phenethylamine oxidase (PEO) and tyramine oxidase (TYO) [29] . Combination of these two genes could lead to the synthesis of phenylethanol and tyrosol from phenylalanine and tyrosine, respectively. The second pathway is mediated by a bifunctional enzyme called aromatic amino acid decarboxylase (AAS) which catalyzes both decarboxylation and oxidation [30, 31] . Microbial systems have been used to synthesize phenylethanoids; for instance, 2-PE was synthesized using various microorganisms. However, 2-PE inhibits microbial growth at a concentration of 2-3 g/l [33] , which limits the use of microorganisms for 2-PE synthesis. Some yeast strains like Pichia fermentansare known to synthesize 2-PE naturally [34] . By optimization of the medium for P. fermentans, 3.71 mM 2-PE was reported to be synthesized [25] . S. cerevisiae and Kiuyveromyces marxianus are typical yeast systems that have been engineered to synthesize increases amounts of 2-PE. Both S. cerevisiae and K. marxianus share the decarboxylase Aro10 that converts phenylpyruvate into phenylacetaldehyde [28, 36] . Phenylalanine was used as a starting material for S. cerevisiae whereas phenylpyruvate was used for K. marxianus (Table 2 ). In S. cerevisiae, Aro9 and Aro10, both of which encode key enzymes for the conversion of phenylalanine into phenylacetaldehyde, were overexpressed along with Aro80 (a transcription activator of Aro9 and Aro10), and Ald3 which encodes aldehyde dehydrogenase, was deleted in order to prevent the conversion of phenylacetaldehyde into phenylacetate. After optimization of the fermentation conditions, 49.93 mM 2-PE was synthesized in S. cerevisiae [36] . In K. marxianus Aro10 and Adh2 (alcohol dehydrogenase) were overexpressed. In addition, aroG
, which is a feedback-inhibition mutant version of aroG and encodes phospho-2-dehydro-3-deoxyheptonate aldolase and catalyzes the condensation of phosphoenolpyruvate (PEP) and erythrose 4-phosphate (E4P) at the first step of the shikimate pathway in Escherichia coli, was overexpressed to increase the phenylalanine concentration. Using these approaches, 10.64 mM 2-PE was synthesized in K. marxianus.
E. coli was also a good system to synthesize 2-PE and its shikimate pathway was well elucidated [37] . In order to increase the phenylalanine and tyrosine production in E. coli, the genes of the shikimate pathway were overexpressed or deleted. AroG and AroF function at the first step of shikimate pathway and condensate phosphoenolpyruvate and erythrose 4-phosphate to form phospho-2-dehydro-3-deoxyheptonate. Overexpression of either of these genes in E. coli resulted in increased phenylalanine and tyrosine production. Two genes, ppsA and tktA, involved in production of PEP and E4P, respectively, were also overexpressed to supply substrates for AroG and AroF. pheA and tyrA were overexpressed to convert chorismate to phenylalanine and tyrosine. In addition, pheA overexpression increased the production of phenylalanine whereas tyrA overexpression increased tyrosine production. The transcription factor TyrR was deleted because it is inhibited by phenylalanine and tyrosine in a feedback manner (Fig. 2) [38] [39] [40] . Two genes from S. cerevisiae, Adh2 and Aro10 were overexpressed in E. coli similar to the approach that was used in S. cerevisiae. Since phenylalanine is a substrate of 2-PE, two genes, aroF encoding phospho-2-dehydro-3-deoxyheptonate aldolase and pheA encoding chorismate mutase/prephenate dehydratase were also overexpressed and the final yield of 2-PE was 2.33 mM [41] . Tyrosol synthesis was mainly investigated in E. coli. TYO from Micrococcus luteus and TDC from Papaver somniferum were overexpressed in E. coli and feaB encoding phenylacetaldehyde dehydrogenase, which has a function similar to ALD3 in S. cerevisiae, was deleted. Using this system, 0.5 mM tyrosol was synthesized [42] . In another study, Aro8 and Aro10 from S. cerevisiae were overexpressed in E. coli and pheA and feaB were deleted, resulting in the synthesis of 4.15 mM tyrosol upon supplying 10 mM tyrosine [43] . By introducing the bifunctional gene AAS into E. coli and engineering the E. coli tyrosine biosynthesis pathway to increase intracellular tyrosine concentration by deleting tyrR and pheA, 3.77 mM tyrosol was synthesized [44] . When more genes (tyrA, ppsA, tktA, aroD, and aroB) of the shikimate pathway of E. coli (Fig. 2) were overexpressed and pykA and pykF, both of which encode pyruvate kinase involved in the conversion of PEP into pyruvate, were deleted, the tyrosol production was 6.71 mM [45] .
Two routes were used for the synthesis of hydroxytyrosol; the first route is through tyrosol and the second route is through dihydroxyphenylalanine (DOPA). HpaBC (hydroxyphenylacetate 3-monooxygenase) from E. coli could convert tyrosol into hydroxytyrol and tyrosine into DOPA (Fig. 1A) [46] [47] [48] . The overexpression of AAS and HpaBC in engineered E. coli resulted in 1.35 mM hydroxytyrosol production [35] . Introducing the other route using TDC and TYO along with HpaBC into E. coli resulted in 1.74 mM hydroxytyrosol production [49] . Instead of HpaBC, TH (tyrosine hydroxylase) along with TDC and TYO was overexpressed. TH uses tetrahydromonapterin (MH4) as a cofactor. To increase tyrosine hydroxylation by supplying more cofactor for TH, two genes, PCD encoding pterin-4a-carbinolamine dehydratase and DHPR encoding dihydropteridine reductase, were overexpressed. The resulting E. coli strain synthesized 0.08 mM hydroxytyrosol from glucose [42] .
Salidroside is a typical phenylethanoid glycoside. The glycosylation of tyrosol into salidroside is catalyzed by uridine diphosphate (UDP) dependent glucosyltransferases (UGTs). Three UGTs (UGT73B6, UGT72B14, and UGT74R1) were isolated from the salidroside producing plant Reynoutriasachalinensis and overexpression of each of these genes in this plant resulted in increased salidroside content [29, 50] . Introduction of UGT73B6 along with the tyrosol biosynthesis genes in E. coli appeared to produce salidroside (0.19 mM) as well as icariside D2 (0.21 mM) [45] . This indicated that UGT73B6 is not specific for salidroside synthesis at least in E. coli. The recent result of tyrosol biotransformation into salidroside using E. coli expressing UGT from Bacillus licheniformis showed the production of both salidroside and icariside D2 [51] . The UGTs found so far attach glucose to both the phenolic hydroxyl group and alcoholic hydroxyl group. Chung et al. [44] screened Arabidopsis thaliana UGTs to synthesize salidroside from tyrosol and found that AtUGT73C5, AtUGT73C6, and AtUGT85A1 specifically synthesized salidroside, and that AtUGT84A1 showed the highest production of salidroside. AtUGT84A1 also converted hydroxytyrosol into salidroside [49] . By combining the tyrosol biosynthesis pathway with AtUGT84A1 in E. coli, 0.99 mM salidroside was synthesized [44] .
CAPE is an ester between phenylethanol and caffeic acid. Caffeic acid is derived from tyrosine and its biosynthetic pathway in plants is well-established. Tyrosine is a starting substance and deamination of tyrosine by tyrosine ammonia lyase (TAL) leads to the synthesis of p-coumaric acid. Subsequent hydroxylation of p-coumaric acid results in caffeic acid formation [48] . The TAL and hydroxylase for p-coumaric acid have been cloned and characterized in plants and microorganisms [52] [53] [54] . However, the in vivo CAPE synthesis pathway is still unknown. Biological synthesis of CAPE using Novozyme 235 (a kind of lipase) has been reported. Two substrates, caffeic acid and 2-PE were mixed in the presence of Novozyme 235 to form CAPE [55] . An esterase (ATF) from S. cerevisiae was used to make a conjugation between caffeoyl-CoA and 2-PE to synthesize CAPE and its derivatives in engineered E. coli [56] . Both the 2-PE biosynthesis pathway and caffeic acid biosynthesis pathway were introduced in E. coli. Notably, the E. coli ydiI (encoding thioesterase) deletion mutant was used, in which caffeoyl-CoA reduces degradation. Thus, by using various metabolic engineering and synthetic biology approaches, approximately 0.21 mM CAPE was synthesized.
Microbial production of phenolic compounds has been studied for the last 15 years. However, the study of phenylethanoid biosynthesis has begun recently and there are many unsolved questions. More genes specific for phenylethanoids are being cloned, and the best combinations among them need to be found. In addition, fine tuning of metabolic pathways and optimization of production processes is needed to improve productivity. In the near future, these obstacles will be overcome and industrial production of some phenylethanoids using microbial systems will be feasible.
